TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: The present study was designed to investigate the cell death-inducing effects of COL-3 on a K562 cell line derived from a CML patient with blast crisis expressing both BCR–ABL and the anti-apoptotic molecule, Bcl-xL, but not the tumor suppressive molecule, p53 [14].